At the news
? BEARISHIMPACT 5/10 8-K filed Apr 27, 2026 at 16:43 ET
Phibro Animal Health disclosed a Brazilian regulatory ban on antimicrobial growth promoters including its virginiamycin and bacitracin products, effective after a 180-day transition period. The company expects limited FY2026 impact and is pursuing therapeutic registrations to mitigate long-term effects.
- Brazilian MAPA Ordinance No. 1617 prohibits use of virginiamycin and bacitracin as growth promoters effective 180 days from April 27, 2026.
- During transition period, sales and use under current labels continue.
- Phibro expects limited impact on fiscal year 2026 results.
- New registrations for therapeutic use of virginiamycin in cattle and broiler chickens are in final MAPA review and expected during transition.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access